Other OTC - Delayed Quote • USD
Aridis Pharmaceuticals, Inc. (ARDS)
As of 9:30 AM EDT. Market Open.
All SEC Filings
Corporate Changes & Voting Matters
Periodic Financial Reports
Proxy Statements
Tender Offer/Acquisition Reports
Offering Registrations
Performance Overview
Trailing total returns as of 4/25/2024, which may include dividends or other distributions. Benchmark is S&P 500
Return | ARDS | S&P 500 |
---|---|---|
YTD | -14.41% | +4.77% |
1-Year | -73.66% | +20.80% |
3-Year | -98.98% | +19.55% |